The NICE Guideline On Medicinal Cannabis: Keeping Pandora's Box Shut Tight?. (4th February 2020)

• Record Type: Journal Article
• Authors: Case, Paula
• Is Part Of: Medical law review. Volume 28:Number 2(2020)
• Page Start: 401
• Page End: 411
• Publication Date: 2020-02-04
• Subjects: Cannabis -- Guideline -- Legalisation -- Medicines -- NICE -- Prescribing; Medical laws and legislation -- Great Britain -- Periodicals; Medical jurisprudence -- Periodicals; Jurisprudence -- Periodicals; Legislation, Medical -- Periodicals; Medical jurisprudence; Medical laws and legislation; Great Britain; 344.41041
• DOI: 10.1093/medlaw/fwaa002
• Languages: English
• ISSNs: 0967-0742

Abstract

Abstract: November 2018 saw the prescription of unlicensed medicinal cannabis products being legalised in the UK, accompanied by loud media fanfare. One year on, it seems that access to medicinal cannabis in this country continues to be extremely rare, raising questions about what might be stopping doctors from making use of the legal space to prescribe. This commentary explores some of these questions, outlining the theoretical space for legal prescribing and examining whether the recently announced National Institute for Health and Care Excellence guideline does anything to ease the deadlock.